Oak Ridge Investments LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Oak Ridge Investments LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	SELL	$144.95 - $152.29 $9,421 - $9,898	-65 Reduced 0.33%	19,884 $3.01 Million
Q2 2022 Jul 28, 2022	SELL	$83.14 - $145.99 $91,038 - $159,859	-1,095 Reduced 5.2%	19,949 $2.91 Million
Q1 2022 Apr 22, 2022	SELL	$110.08 - $142.92 $1.36 Million - $1.77 Million	-12,351 Reduced 36.98%	21,044 $2.5 Million
Q4 2021 Feb 01, 2022	SELL	$99.73 - $148.48 $56,846 - $84,633	-570 Reduced 1.68%	33,395 $4.6 Million
Q3 2021 Nov 05, 2021	SELL	$98.85 - $138.91 $124,847 - $175,443	-1,263 Reduced 3.59%	33,965 $4.72 Million
Q2 2021 Jul 30, 2021	SELL	$65.78 - $105.02 $168,528 - $269,061	-2,562 Reduced 6.78%	35,228 $3.42 Million
Q1 2021 May 12, 2021	SELL	$64.07 - $91.75 $16.9 Million - $24.2 Million	-264,301 Reduced 87.49%	37,790 $2.58 Million
Q1 2021 May 04, 2021	BUY	$64.07 - $91.75 $16.9 Million - $24.2 Million	263,821 Added 689.37%	302,091 $20.6 Million
Q4 2020 Feb 03, 2021	SELL	$65.07 - $98.24 $577,235 - $871,487	-8,871 Reduced 18.82%	38,270 $3.28 Million
Q3 2020 Nov 12, 2020	BUY	$59.04 - $77.95 $2.78 Million - $3.67 Million	47,141 New	47,141 $3.07 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Oak Ridge Investments LLC with notifications on news.